CDTI R+D national program

CDTI, the Spanish public entity for the promotion of research and innovation in Spain, has awarded and awarded to our company last December 2021 a grant to collaborate in the development of our automated telemedicine platform.

The aid consists of a subsidized loan for an amount of 382K euros in 10 years, without interest, with a released, non-refundable tranche of 101K euros at the end.

Aid value: 382K euros
Granted: 101K euros
Ending: November 2022

This content is restricted to Investors. If you are an existing investor, please log in.

Become an investor!.

 Other research projects

COVID-19 project

COVID-19 project

We are conducting a hospital clinical trial to measure the infectivity of the SARS-CoV-2 virus and slow down the replication of the virus in host cells.